Icone

The medical center is at the forefront of breast cancer research, focusing on innovative treatments for node-positive, estrogen receptor-positive, HER2-negative, early breast cancer with a high risk of recurrence. The center's research aims to improve invasive breast cancer-free survival through advanced therapeutic strategies.

• Elacestrant versus Standard Endocrine Therapy
• Invasive Breast Cancer-Free Survival
• High-Risk Recurrence Management

By conducting global, multicenter studies, the center contributes significantly to the understanding and treatment of complex breast cancer cases, offering hope for improved patient outcomes.

Specializing in colorectal cancer, the medical center is pioneering research in the treatment of advanced unresectable KRAS G12C mutated colorectal adenocarcinoma. The focus is on enhancing progression-free survival using targeted therapies for patients who are not eligible for traditional chemotherapy regimens.

• 5-Fluorouracil plus panitumumab and sotorasib
• KRAS G12C Mutation Targeting
• First-Line Treatment Innovations

Through cutting-edge clinical trials, the center is advancing the field of colorectal cancer treatment, providing new avenues for patients with limited options and improving quality of life.